Actor
Chord Therapeutics
Clinical stage pharmaceutical company developing drugs for patients with rare, life-threatening and severely disabling diseases.
We are advancing our lead drug candidate CRD1 under orphan drug designation for the treatment of neuromyelitis optica spectrum disorders (NMOSD) and myasthenia gravis (MG)
Specialties
Primary Therapeutic Areas
1.0 Therapeutic & Diagnostic
1.10 Small Molecules
Business model
1. Entreprise
1.1 Start-Up
Organization Type
Private Company
Visit website
Domains
Neurology
Main sector
Biotech
Contact
Rue de Berne 11
1201 Geneva / GE